OM:VITRBiotechs
Vitrolife (OM:VITR) Stock Faces Recovery Questions As Q2 Profit Contrasts 4.98b TTM Loss
Vitrolife (OM:VITR) has reported Q2 2026 revenue of SEK857 million with EPS of SEK0.95, while the trailing twelve months still show a loss of SEK4.98 billion and EPS of SEK36.80 in the red. The company has seen quarterly revenue move from SEK871 million in Q2 2025 to SEK892 million in Q4 2025 and SEK807 million in Q1 2026, with EPS shifting from SEK0.74 to a loss of SEK39.23 and then back to SEK0.75 and SEK0.95 most recently. This gives investors a mixed picture of earnings power around...